Despite the availability of effective therapies that lower low‐density lipoprotein cholesterol
(LDL‐C) levels in patients with atherosclerotic cardiovascular disease, many eligible …

Background Recent advances in telecommunications technology have raised the possibility
of telehealth intervention delivering cardiac telerehabilitation, which may provide the efficacy …

Dyslipidemia, an imbalance of lipids and a major risk factor for cardiovascular disease, has
been associated with elevated blood and urine levels of several heavy metals. Using data …

Objectives This study aimed to evaluate the association between increased lipoprotein
(a)[Lp (a)] and long-term outcomes in patients undergoing percutaneous coronary …

To improve cholesterol management in ASCVD patients will require an integrated approach
targeting the provider, the patient and the system. There is a need for further education of …

Introduction A high proportion of Canadian patients with acute myocardial infarction (AMI) do
not achieve the threshold low-density lipoprotein cholesterol (LDL-C) levels recommended …

Aims Using rosuvastatin, the RACING (randomized comparison of efficacy and safety of lipid-
lowering with statin monotherapy versus statin/ezetimibe combination for high-risk …

Purpose We aimed to establish and authenticate a clinical prognostic nomogram for
predicting long-term Major Adverse Cardiovascular Events (MACEs) among high-risk …

Objective This study aimed to investigate the predictive value of a clinical nomogram model
based on serum YKL-40 for major adverse cardiovascular events (MACE) during …

Background Effective control of risk factors in patients with ASCVD is important to reduce
recurrent cardiovascular events. However, many ASCVD patients do not have their risk …